• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study.与埃塞俄比亚 COVID-19 患者出现症状性疾病相关的因素:一项病例对照研究。
BMC Infect Dis. 2021 Aug 5;21(1):759. doi: 10.1186/s12879-021-06465-1.
2
COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.COVID-19 疾病严重程度及相关因素分析:来自千年 COVID-19 关爱中心的研究。
PLoS One. 2022 Jan 27;17(1):e0262896. doi: 10.1371/journal.pone.0262896. eCollection 2022.
3
Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.住院的非洲 COVID-19 患者的特征和预后概况:埃塞俄比亚的情况。
PLoS One. 2021 Nov 9;16(11):e0259454. doi: 10.1371/journal.pone.0259454. eCollection 2021.
4
Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study.在埃塞俄比亚千禧年 COVID-19 护理中心,严重 COVID-19 患者死亡的预测因素:一项病例对照研究。
Pan Afr Med J. 2021 Apr 12;38:351. doi: 10.11604/pamj.2021.38.351.28831. eCollection 2021.
5
The applicability of basic preventive measures of the pandemic COVID-19 and associated factors among residents in Guraghe Zone.《格扎地区居民中 COVID-19 大流行基本预防措施的适用性及相关因素》
PLoS One. 2021 Aug 25;16(8):e0256598. doi: 10.1371/journal.pone.0256598. eCollection 2021.
6
Assessment of hypertension and other factors associated with the severity of disease in COVID-19 pneumonia, Addis Ababa, Ethiopia: A case-control study.评估 COVID-19 肺炎中与疾病严重程度相关的高血压和其他因素,埃塞俄比亚亚的斯亚贝巴:一项病例对照研究。
PLoS One. 2022 Aug 15;17(8):e0273012. doi: 10.1371/journal.pone.0273012. eCollection 2022.
7
Factors Associated with Poor Treatment Outcome among Hospitalized COVID-19 Patients in South Central, Ethiopia.与埃塞俄比亚中南部住院 COVID-19 患者治疗结果不良相关的因素。
Biomed Res Int. 2022 Feb 23;2022:4551132. doi: 10.1155/2022/4551132. eCollection 2022.
8
Knowledge of COVID-19 and its prevention among residents of the Gedeo zone, South Ethiopia. Sources of information as a factor.埃塞俄比亚南部盖多地区居民对 COVID-19 及其预防措施的认知。信息来源作为一个因素。
Curr Med Res Opin. 2020 Dec;36(12):1955-1960. doi: 10.1080/03007995.2020.1835854. Epub 2020 Oct 23.
9
Anxiety and associated factors among Ethiopian health professionals at early stage of COVID-19 pandemic in Ethiopia.COVID-19 大流行早期埃塞俄比亚卫生专业人员的焦虑及其相关因素。
PLoS One. 2021 Jun 8;16(6):e0252664. doi: 10.1371/journal.pone.0252664. eCollection 2021.
10
Knowledge, attitude and preventive practice towards COVID-19 and associated factors among outpatient service visitors at Debre Markos compressive specialized hospital, north-west Ethiopia, 2020.2020 年,在埃塞俄比亚西北部的德布雷马科斯综合专科医院,对门诊服务访客进行了 COVID-19 相关知识、态度和预防措施及其影响因素的调查。
PLoS One. 2021 Jul 15;16(7):e0251708. doi: 10.1371/journal.pone.0251708. eCollection 2021.

引用本文的文献

1
Causal Inference of the Effect of Vaccination on COVID-19 Disease Severity and Need for Intensive Care Unit Admission Among Hospitalized Patients in an African Setting.非洲地区住院患者中疫苗接种对新冠病毒疾病严重程度及重症监护病房收治需求影响的因果推断
Cureus. 2024 Aug 25;16(8):e67719. doi: 10.7759/cureus.67719. eCollection 2024 Aug.
2
Assessment of the hematological profiles among COVID-19 patients during the first and second waves in Ethiopia: A multicenter retrospective cohort study.埃塞俄比亚第一波和第二波新冠疫情期间新冠患者血液学指标评估:一项多中心回顾性队列研究
SAGE Open Med. 2024 May 20;12:20503121241253522. doi: 10.1177/20503121241253522. eCollection 2024.
3
Comparison of self-reported symptoms in COVID-19 patients who had or had not previously received COVID-19 mRNA vaccination.比较曾接种或未接种 COVID-19 mRNA 疫苗的 COVID-19 患者的自我报告症状。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2226575. doi: 10.1080/21645515.2023.2226575.
4
Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era.明尼苏达州奥尔姆斯特德县疫苗接种前时代无症状新冠病毒感染率及相关因素
Mayo Clin Proc Innov Qual Outcomes. 2022 Dec;6(6):605-617. doi: 10.1016/j.mayocpiqo.2022.10.001. Epub 2022 Oct 18.
5
First wave COVID-19 pandemic in Senegal: Epidemiological and clinical characteristics.塞内加尔的第一波 COVID-19 大流行:流行病学和临床特征。
PLoS One. 2022 Sep 20;17(9):e0274783. doi: 10.1371/journal.pone.0274783. eCollection 2022.
6
Clinical Characteristics and Treatment Outcomes of COVID-19 Patients at Eka Kotebe General Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴埃卡·科特贝综合医院的 COVID-19 患者的临床特征和治疗结果。
Am J Trop Med Hyg. 2022 Jul 5;107(2):252-259. doi: 10.4269/ajtmh.21-1270. Print 2022 Aug 17.
7
Factors Associated with Poor Treatment Outcome among Hospitalized COVID-19 Patients in South Central, Ethiopia.与埃塞俄比亚中南部住院 COVID-19 患者治疗结果不良相关的因素。
Biomed Res Int. 2022 Feb 23;2022:4551132. doi: 10.1155/2022/4551132. eCollection 2022.
8
COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.COVID-19 疾病严重程度及相关因素分析:来自千年 COVID-19 关爱中心的研究。
PLoS One. 2022 Jan 27;17(1):e0262896. doi: 10.1371/journal.pone.0262896. eCollection 2022.
9
Sex-Related Factors in Cardiovascular Complications Associated to COVID-19.与 COVID-19 相关心血管并发症的性别因素。
Biomolecules. 2021 Dec 24;12(1):21. doi: 10.3390/biom12010021.
10
Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.住院的非洲 COVID-19 患者的特征和预后概况:埃塞俄比亚的情况。
PLoS One. 2021 Nov 9;16(11):e0259454. doi: 10.1371/journal.pone.0259454. eCollection 2021.

本文引用的文献

1
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.与美国 2019 年冠状病毒病危重症患者死亡相关的因素。
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. doi: 10.1001/jamainternmed.2020.3596.
2
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
3
Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19.血浆血管紧张素转换酶2:心力衰竭中的新型生物标志物及其对2019冠状病毒病的影响
Eur Heart J. 2020 May 14;41(19):1818-1820. doi: 10.1093/eurheartj/ehaa414.
4
Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19.无症状和有症状轻症 COVID-19 患者的临床特征。
Clin Microbiol Infect. 2020 Jul;26(7):948.e1-948.e3. doi: 10.1016/j.cmi.2020.04.040. Epub 2020 May 1.
5
COVID-19 presenting as stroke.COVID-19 以中风为表现形式。
Brain Behav Immun. 2020 Jul;87:115-119. doi: 10.1016/j.bbi.2020.04.077. Epub 2020 Apr 28.
6
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.2019 新型冠状病毒病(COVID-19)合并炎症性肠病患者。
Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. doi: 10.1111/apt.15804. Epub 2020 Jun 7.
7
Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.2019年冠状病毒病(COVID-19)住院患者的临床特征、实验室检查结果及预后:来自美国的早期报告
Diagnosis (Berl). 2020 May 26;7(2):91-96. doi: 10.1515/dx-2020-0046.
8
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
9
Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.无症状 SARS-CoV-2 感染患者的流行病学和临床特征。
J Med Virol. 2020 Oct;92(10):1884-1889. doi: 10.1002/jmv.25944. Epub 2020 May 12.
10
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis.新型冠状病毒病 2019(COVID-19)的患病率和严重程度:系统评价和荟萃分析。
J Clin Virol. 2020 Jun;127:104371. doi: 10.1016/j.jcv.2020.104371. Epub 2020 Apr 14.

与埃塞俄比亚 COVID-19 患者出现症状性疾病相关的因素:一项病例对照研究。

Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study.

机构信息

Department of Internal Medicine, Research Development Office, Millennium COVID-19 Care Center, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

出版信息

BMC Infect Dis. 2021 Aug 5;21(1):759. doi: 10.1186/s12879-021-06465-1.

DOI:10.1186/s12879-021-06465-1
PMID:34353283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8339680/
Abstract

BACKGROUND

Studies show that having some symptoms seems to be associated with more severe disease and poor prognosis. Therefore, knowing who is more susceptible to symptomatic COVID-19 disease is important to provide targeted preventive and management practice. The aim of the study was to assess factors associated with the development of symptomatic disease among COVID-19 patients admitted to Millennium COVID-19 Care Center in Ethiopia.

METHODS

A case-control study was conducted from August to September 2020 among a randomly selected 730 COVID-19 patients (337 Asymptomatic and 393 Symptomatic patients). Chi-square test and independent t-test were used to detect the presence of a statistically significant difference in the characteristics of the cases (symptomatic) and controls (asymptomatic), where p-value of < 0.05 considered as having a statistically significant difference. Multivariable binary logistic regression was used to assess a statistically significant association between the independent variables and developing symptomatic COVID-19 where Adjusted Odds ratio (AOR), 95% CIs for AOR, and P-values were used for testing significance and interpretation of results.

RESULTS

The result of the multivariable binary logistic regression shows that age group (AOR = 1.89, 95% CI = 1.25, 2.87, p-value = 0.002 for 30-39 years; AOR = 1.69, 95% CI = 1.06, 2.73, p-value = 0.028 for 40-49 years and AOR = 4.42, 95% CI = 2.75, 7.12, p-value = 0.0001 for ≥50 years), sex (AOR = 1.76, 95% CI = 1.26, 2.45, p-value = 0.001) and history of diabetes mellitus (AOR = 3.90, 95% CI = 1.92, 7.94, p-value = 0.0001) were found to be significant factors that determine the development of symptomatic disease in COVID-19 patients.

CONCLUSIONS

Developing a symptomatic COVID-19 disease was found to be associated with exposures of old age, male sex, and being diabetic. Therefore, patients with the above factors should be given enough attention in the prevention and management process, including inpatient management, to pick symptoms earlier and to manage accordingly so that these patients can have a favorable treatment outcome.

摘要

背景

研究表明,出现某些症状似乎与疾病更严重和预后不良有关。因此,了解哪些人更容易患上有症状的 COVID-19 疾病,对于提供有针对性的预防和管理措施非常重要。本研究旨在评估与埃塞俄比亚千年 COVID-19 护理中心收治的 COVID-19 患者出现有症状疾病相关的因素。

方法

2020 年 8 月至 9 月期间,采用病例对照研究方法,随机选择 730 名 COVID-19 患者(337 名无症状和 393 名有症状患者)。卡方检验和独立 t 检验用于检测病例(有症状)和对照(无症状)特征是否存在统计学显著差异,p 值<0.05 被认为具有统计学显著差异。多变量二项逻辑回归用于评估独立变量与发展为有症状 COVID-19 之间的统计学显著关联,使用调整后的优势比(AOR)、AOR 的 95%置信区间(CI)和 P 值用于检验显著性和解释结果。

结果

多变量二项逻辑回归的结果表明,年龄组(AOR=1.89,95%CI=1.25,2.87,p 值=0.002,30-39 岁;AOR=1.69,95%CI=1.06,2.73,p 值=0.028,40-49 岁;AOR=4.42,95%CI=2.75,7.12,p 值=0.0001,≥50 岁)、性别(AOR=1.76,95%CI=1.26,2.45,p 值=0.001)和糖尿病史(AOR=3.90,95%CI=1.92,7.94,p 值=0.0001)被发现是确定 COVID-19 患者出现有症状疾病的重要因素。

结论

出现有症状的 COVID-19 疾病与暴露于老年、男性和糖尿病有关。因此,在预防和管理过程中,应给予具有上述因素的患者足够的关注,包括住院管理,以便更早地发现症状并进行相应的管理,从而使这些患者获得良好的治疗效果。